Mina Levy
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Enzyme function and inhibition 2
- Glycosylation and Glycoproteins Research 1
-
- Cancer, Hypoxia, and Metabolism 4
- Co-authors
- Harry Eagle (14 shared papers)Ralph Fleischman (4 shared papers)Vance I. Oyama (5 shared papers)Aaron E. Freeman (3 shared papers)Henry O. Schulze (1 shared paper)Stanley Barban (1 shared paper)Karl A. Piez (1 shared paper)Andrew Freeman (1 shared paper)
- Journals
- Journal of Biological Chemistry (6 papers)Journal of Bacteriology (2 papers)Science (2 papers)Experimental Biology and Medicine (1 paper)New England Journal of Medicine (1 paper)
- Partner nations
- United StatesNorth MacedoniaIsrael
In The Last Decade
Mina Levy
18 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 107
- Molecular Medicine 108
- Cancer Research 236
- Clinical Biochemistry 110
- Biochemistry 120
- Applied Microbiology and Biotechnology 25
Countries citing papers authored by Mina Levy
This map shows the geographic impact of Mina Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mina Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mina Levy more than expected).
Fields of papers citing papers by Mina Levy
This network shows the impact of papers produced by Mina Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mina Levy. The network helps show where Mina Levy may publish in the future.
Co-authors
The 18 scholars most cited alongside Mina Levy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1956 | 301 | |
| 2 | 1957 | 246 | |
| 3 | 1953 | 198 | |
| 4 | 1958 | 194 | |
| 5 | 1961 | 106 | |
| 6 | 1965 | 41 | |
| 7 | 1966 | 40 | |
| 8 | 1957 | 39 | |
| 9 | 1992 | 36 | |
| 10 | 1958 | 34 | |
| 11 | 1952 | 32 | |
| 12 | 1964 | 24 | |
| 13 | On the duration of penicillin action in relation to its concentration in the serum. | 1953 | 24 |
| 14 | 1956 | 15 | |
| 15 | 1955 | 11 | |
| 16 | 1953 | 6 | |
| 17 | 1956 | 5 | |
| 18 | 1951 | 1 |
About Mina Levy
Mina Levy is a scholar working on Molecular Biology, Cancer Research, Pharmacology, Biochemistry and Infectious Diseases, having authored 18 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Amino Acid Enzymes and Metabolism (3 papers), Drug-Induced Adverse Reactions (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Enzyme function and inhibition (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Jewish and Middle Eastern Studies (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Molecular Medicine (108 citations), Cancer Research (236 citations), Clinical Biochemistry (110 citations), Biochemistry (120 citations) and Applied Microbiology and Biotechnology (25 citations). Mina Levy has collaborated with scholars based in United States, North Macedonia and Israel. Frequent co-authors include Harry Eagle, Ralph Fleischman, Vance I. Oyama, Aaron E. Freeman, Henry O. Schulze, Stanley Barban, Karl A. Piez, Andrew Freeman, Leonard A. Cohen and Robert W. Fleischman. Their work appears in journals such as Journal of Biological Chemistry, Journal of Bacteriology, Science, Experimental Biology and Medicine and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.